Recent News from the Community

New grant will fund research of biomechanical markers in glaucoma

This study may explain why individuals of African descent are at the greatest risk of developing glaucoma.Massimo A. Fazio, Ph.D., assistant professor in the University of Alabama at Birmingham Department of Ophthalmology, and Christopher A. Girkin M.D., have received a four-year, $2.55 million R01 grant from the National Eye Institute to explore how visual field ...

UAH alumnus envisioning pressing health issue solutions

UAH alumnus Jim Hudson is a founder of HudsonAlpha Institute for Biotechnology in Huntsville. When HudsonAlpha Institute for Biotechnology opened its doors in 2008, founders Jim Hudson (’87 MS, Biology) and Lonnie McMillian envisioned a place where scientists, entrepreneurs and educators would come together to solve some of the world’s most pressing health issues. Today, HudsonAlpha ...
news categories: ,

Bioscience – Made in Alabama

Alabama is home to more than 800 bioscience companies, including 54 medical device companies, and a long list of accolades that accompany them. Birmingham-based Southern Research, for instance, has discovered seven FDA-approved drugs used in cancer treatment, and has made important advances in the treatment of AIDS, polio, and mosquito-borne viruses. The HudsonAlpha Institute for ...
news categories: ,

Cancer researchers at Southern Research pursue new immunotherapy drug approach

Southern Research scientists are targeting a mechanism used by tumor cells to disarm the human immune system as they work to develop a new drug that’s effective against multiple forms of cancer and easy to administer as a pill. The Southern Research team is building on a successful strategy in immunotherapy – prevent a protein from ...
news categories: ,

UAB spinoff scores key European patent in cancer fight

A novel approach to fighting cancer being developed in Birmingham that is in a preclinical phase has received a European patent.

The University of Alabama at Birmingham, Emory University and Children’s Healthcare of Atlanta have partnered to create biopharmaceutical company Incysus Ltd.

news categories: ,

HudsonAlpha kicks off BioTrain today!

Today HudsonAlpha launched BioTrain 2017.   The BioTrain Internship program offers students the opportunity to connect classwork with real‐world job experience and gain skills and knowledge that will prepare them for careers in biotechnology and related fields. Summer internships are available for undergraduate through master’s level graduate students, providing experiences that range from in‐depth laboratory research to ...
news categories: ,

Innovation Depot firm, BioGX, expands to Netherlands

BioGX, a developer and manufacturer of molecular diagnostics CE-IVD tests, has announced the establishment of European operations based in Amsterdam, Netherlands.

news categories: ,

Biotech firm Blondin to collaborate on breast cancer research project in Finland

BIRMINGHAM, Alabama – A key executive for Blondin Bioscience LLC is a collaborator on a prestigious grant awarded by the Academy of Finland that will aid in the study of breast cancer therapies.

news categories: ,

Southern Research initiates intensive TrainSafe biosafety training program

Southern Research is launching a new biosafety training center as the centerpiece of an advanced program called TrainSafe to teach health care workers and laboratory staff how to protect themselves against pathogens responsible for serious infectious diseases.

news categories: ,

Alabama biotech leaders build ties on Europe trade mission

Leaders in Alabama’s life sciences industry arrived in Denmark late last week for the second leg of a trade mission aimed at seeking new markets in Europe for their products and encouraging new investment in the state sector.

news categories: